ym 09151-2 has been researched along with bromocriptine in 2 studies
Studies (ym 09151-2) | Trials (ym 09151-2) | Recent Studies (post-2010) (ym 09151-2) | Studies (bromocriptine) | Trials (bromocriptine) | Recent Studies (post-2010) (bromocriptine) |
---|---|---|---|---|---|
249 | 6 | 13 | 7,121 | 727 | 499 |
Protein | Taxonomy | ym 09151-2 (IC50) | bromocriptine (IC50) |
---|---|---|---|
5-hydroxytryptamine receptor 4 | Cavia porcellus (domestic guinea pig) | 0.532 | |
Beta-1 adrenergic receptor | Homo sapiens (human) | 2.4 | |
Cytochrome P450 3A4 | Homo sapiens (human) | 2.4996 | |
Alpha-2A adrenergic receptor | Homo sapiens (human) | 0.015 | |
D(2) dopamine receptor | Homo sapiens (human) | 0.0016 | |
Androgen receptor | Rattus norvegicus (Norway rat) | 2.281 | |
Alpha-2B adrenergic receptor | Homo sapiens (human) | 0.035 | |
Alpha-2C adrenergic receptor | Homo sapiens (human) | 0.52 | |
D | Rattus norvegicus (Norway rat) | 0.0279 | |
D(3) dopamine receptor | Rattus norvegicus (Norway rat) | 0.0279 | |
5-hydroxytryptamine receptor 1A | Rattus norvegicus (Norway rat) | 0.0056 | |
Alpha-2B adrenergic receptor | Rattus norvegicus (Norway rat) | 0.514 | |
D(1A) dopamine receptor | Homo sapiens (human) | 2.889 | |
Alpha-2C adrenergic receptor | Rattus norvegicus (Norway rat) | 0.514 | |
Alpha-2A adrenergic receptor | Rattus norvegicus (Norway rat) | 0.514 | |
Alpha-1D adrenergic receptor | Homo sapiens (human) | 0.03 | |
D(1B) dopamine receptor | Rattus norvegicus (Norway rat) | 0.0279 | |
5-hydroxytryptamine receptor 2A | Homo sapiens (human) | 0.036 | |
5-hydroxytryptamine receptor 2C | Homo sapiens (human) | 0.532 | |
5-hydroxytryptamine receptor 1B | Rattus norvegicus (Norway rat) | 0.0056 | |
D(4) dopamine receptor | Rattus norvegicus (Norway rat) | 0.0279 | |
D(3) dopamine receptor | Homo sapiens (human) | 0.0006 | |
5-hydroxytryptamine receptor 2B | Homo sapiens (human) | 0.0083 | |
5-hydroxytryptamine receptor 6 | Homo sapiens (human) | 0.022 | |
D(2) dopamine receptor | Rattus norvegicus (Norway rat) | 0.0279 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Beaulieu, M; Felder, R; Kebabian, JW | 1 |
Kamijo, N; Nagao, T; Ono, H | 1 |
2 other study(ies) available for ym 09151-2 and bromocriptine
Article | Year |
---|---|
D-2 dopaminergic agonists and adenosine 3',5'-monophosphate directly regulate the synthesis of alpha-melanocyte-stimulating hormone-like peptides by cultured rat melanotrophs.
Topics: 1-Methyl-3-isobutylxanthine; 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; 8-Bromo Cyclic Adenosine Monophosphate; Animals; Benzamides; Benzazepines; Bromocriptine; Cells, Cultured; Chemical Precipitation; Cholera Toxin; Chromatography, High Pressure Liquid; Colforsin; Cyclic AMP; Dopamine; Ergolines; Immunologic Techniques; Melanocyte-Stimulating Hormones; Pituitary Gland; Pro-Opiomelanocortin; Quinpirole; Rats; Receptors, Dopamine; Spiperone | 1986 |
Depression of the monosynaptic reflex by apomorphine or bromocriptine is not mediated by D1/D2 receptors.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Apomorphine; Benzamides; Bromocriptine; Decerebrate State; Depression, Chemical; Dopamine Agents; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Ergolines; Male; Quinpirole; Rats; Rats, Wistar; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Dopamine D3; Reflex, Monosynaptic; Sulpiride; Synaptic Transmission | 1993 |